BCM
SRTA

Bayesian Capital Management’s Strata Critical Medical Inc SRTA Stock Holding History

Bayesian Capital Management’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,200
Closed -$27.8K – 560
2025
Q1 		$27.8K Buy
+10,200
New +$36.6K ﹤0.01% 566
2024
Q1 		– Sell
-17,200
Closed -$60.7K – 790
2023
Q4 		$60.7K Buy
17,200
+2,400
+16% +$6.89K 0.01% 675
2023
Q3 		$38.3K Buy
+14,800
New +$52K ﹤0.01% 646

Other funds holding SRTA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Bayesian Capital Management's SRTA Position: Q2 2025 in Review

Bayesian Capital Management sold out of Strata Critical Medical Inc (SRTA) in Q2 2025, closing a stake of 10,200 shares — an estimated $27.8K sold.

Bayesian Capital Management first reported a position in SRTA in Q3 2023 and held it in 3 quarters. The position peaked at $60.7K in Q4 2023. 126 funds tracked by Wall St. Rank hold SRTA as of Q2 2025.

  • Bayesian Capital Management reported no remaining Strata Critical Medical Inc position as of Q2 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 10,200 Strata Critical Medical Inc shares in Q2 2025, an estimated $27.8K.
  • Bayesian Capital Management first reported a position in Strata Critical Medical Inc in Q3 2023 and held it in 3 quarters.
  • Bayesian Capital Management's Strata Critical Medical Inc position peaked at $60.7K in Q4 2023.
  • 126 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2025.

Based on Bayesian Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.